Magnetic Resonance Quantitative Susceptibility Mapping in the Evaluation of Hepatic Fibrosis in Chronic Liver Disease: a Feasibility Study

Overview

Journal Quant Imaging Med Surg

Specialty Radiology

Date 2021 Apr 5

PMID 33816158

Citations 5

Authors

Zheng Qu

Shuohui Yang

Feng Xing

Rui Tong

Chenyao Yang

Rongfang Guo

Jiling Huang

Fang Lu

Caixia Fu

Xu Yan

Stefanie Hectors

Kelly Gillen

Yi Wang

Chenghai Liu

Songhua Zhan

Jianqi Li

Affiliations

Soon will be listed here.

Abstract

Background: Noninvasive methods for the early diagnosis and staging of hepatic fibrosis are needed. The present study aimed to investigate the alteration of magnetic susceptibility in the liver of patients with various fibrosis stages and to evaluate the feasibility of using susceptibility to stage hepatic fibrosis.

Methods: A total of 30 consecutive patients with chronic liver diseases (CLDs) underwent magnetic resonance imaging (MRI) and liver biopsy evaluation of hepatic fibrosis, necroinflammatory activity, iron load, and steatosis. Quantitative susceptibility mapping (QSM), R2* and proton density fat fraction (PDFF) images were postprocessed from the same gradient-echo data for quantitative tissue characterization using region of interest (ROI) analysis. The differences for MRI measurements between cohorts of non-significant (Ishak-F <3) and significant fibrosis (Ishak-F ≥3) and the correlation of MRI measurements with fibrosis stages and necroinflammatory activity grades were tested. Receiver operating characteristic (ROC) analysis was also performed.

Results: There was a significant difference in liver susceptibility between the cohorts of significant and non-significant fibrosis (Z=-2.880, P=0.004). A moderate negative correlation between the stages of liver fibrosis and liver susceptibility was observed (r=-0.471, P=0.015). Liver magnetic susceptibility differentiated non-significant from significant hepatic fibrosis with an area under the receiver operating curve (AUC) of 0.836 (P=0.004). A highly sensitive diagnostic performance with an AUC of 0.933 was obtained using magnetic susceptibility and PDFF together (P<0.001).

Conclusions: A noninvasive liver QSM-based evaluation promises an accurate assessment of significant fibrosis in patients with CLDs.

Citing Articles

Quantitative susceptibility mapping for iron monitoring of multiple subcortical nuclei in type 2 diabetes mellitus: a systematic review and meta-analysis.

Mohammadi S, Ghaderi S, Sayehmiri F, Fathi M Front Endocrinol (Lausanne). 2024; 15:1331831.

PMID: 38510699 PMC: 10950952. DOI: 10.3389/fendo.2024.1331831.

Free-breathing high isotropic resolution quantitative susceptibility mapping (QSM) of liver using 3D multi-echo UTE cones acquisition and respiratory motion-resolved image reconstruction.

Kang M, Behr G, Jafari R, Gambarin M, Otazo R, Kee Y Magn Reson Med. 2023; 90(5):1844-1858.

PMID: 37392413 PMC: 10529485. DOI: 10.1002/mrm.29779.

Renal ischemia-reperfusion injury in rabbits evaluated with quantitative susceptibility mapping: an animal study.

Luo K, Yu A, Fu Q, Pan L, Dou W, Zhang J Quant Imaging Med Surg. 2023; 13(4):2441-2450.

PMID: 37064358 PMC: 10102784. DOI: 10.21037/qims-22-838.

QSM Throughout the Body.

Dimov A, Li J, Nguyen T, Roberts A, Spincemaille P, Straub S J Magn Reson Imaging. 2023; 57(6):1621-1640.

PMID: 36748806 PMC: 10192074. DOI: 10.1002/jmri.28624.

Toward a realistic in silico abdominal phantom for QSM.

Silva J, Milovic C, Lambert M, Montalba C, Arrieta C, Irarrazaval P Magn Reson Med. 2023; 89(6):2402-2418.

PMID: 36695213 PMC: 10952412. DOI: 10.1002/mrm.29597.

References

Kawada N . Evolution of hepatic fibrosis research. Hepatol Res. 2011; 41(3):199-208. DOI: 10.1111/j.1872-034X.2011.00776.x. View

Seto W, Hui R, Mak L, Fung J, Cheung K, Liu K . Association Between Hepatic Steatosis, Measured by Controlled Attenuation Parameter, and Fibrosis Burden in Chronic Hepatitis B. Clin Gastroenterol Hepatol. 2017; 16(4):575-583.e2. DOI: 10.1016/j.cgh.2017.09.044. View

Allkemper T, Sagmeister F, Cicinnati V, Beckebaum S, Kooijman H, Kanthak C . Evaluation of fibrotic liver disease with whole-liver T1ρ MR imaging: a feasibility study at 1.5 T. Radiology. 2014; 271(2):408-15. DOI: 10.1148/radiol.13130342. View

Bedossa P, Poynard T . An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology. 1996; 24(2):289-93. DOI: 10.1002/hep.510240201. View

Zhou D, Cho J, Zhang J, Spincemaille P, Wang Y . Susceptibility underestimation in a high-susceptibility phantom: Dependence on imaging resolution, magnitude contrast, and other parameters. Magn Reson Med. 2016; 78(3):1080-1086. DOI: 10.1002/mrm.26475. View

Spincemaille P, Liu Z, Zhang S, Kovanlikaya I, Ippoliti M, Makowski M . Clinical Integration of Automated Processing for Brain Quantitative Susceptibility Mapping: Multi-Site Reproducibility and Single-Site Robustness. J Neuroimaging. 2019; 29(6):689-698. PMC: 6814493. DOI: 10.1111/jon.12658. View

Dimov A, Liu T, Spincemaille P, Ecanow J, Tan H, Edelman R . Joint estimation of chemical shift and quantitative susceptibility mapping (chemical QSM). Magn Reson Med. 2014; 73(6):2100-10. PMC: 4874185. DOI: 10.1002/mrm.25328. View

Liu T, Khalidov I, de Rochefort L, Spincemaille P, Liu J, Tsiouris A . A novel background field removal method for MRI using projection onto dipole fields (PDF). NMR Biomed. 2011; 24(9):1129-36. PMC: 3628923. DOI: 10.1002/nbm.1670. View

Wei H, Decker K, Nguyen H, Cao S, Tsai T, Dianne Guy C . Imaging diamagnetic susceptibility of collagen in hepatic fibrosis using susceptibility tensor imaging. Magn Reson Med. 2019; 83(4):1322-1330. DOI: 10.1002/mrm.27995. View

10.

Karsa A, Punwani S, Shmueli K . The effect of low resolution and coverage on the accuracy of susceptibility mapping. Magn Reson Med. 2018; 81(3):1833-1848. PMC: 6492151. DOI: 10.1002/mrm.27542. View

11.

Hagiwara M, Rusinek H, Lee V, Losada M, Bannan M, Krinsky G . Advanced liver fibrosis: diagnosis with 3D whole-liver perfusion MR imaging--initial experience. Radiology. 2008; 246(3):926-34. DOI: 10.1148/radiol.2463070077. View

12.

Wang Y, Wang X, Wu P, Wang Y, Chen W, Chen H . Topics on quantitative liver magnetic resonance imaging. Quant Imaging Med Surg. 2019; 9(11):1840-1890. PMC: 6902134. DOI: 10.21037/qims.2019.09.18. View

13.

Zhao F, Zhou N, Wang J, Zhou H, Zou L, Zhong W . Collagen deposition in the liver is strongly and positively associated with T1rho elongation while fat deposition is associated with T1rho shortening: an experimental study of methionine and choline-deficient (MCD) diet rat model. Quant Imaging Med Surg. 2020; 10(12):2307-2321. PMC: 7596395. DOI: 10.21037/qims-20-651. View

14.

Annet L, Peeters F, Abarca-Quinones J, Leclercq I, Moulin P, Van Beers B . Assessment of diffusion-weighted MR imaging in liver fibrosis. J Magn Reson Imaging. 2006; 25(1):122-8. DOI: 10.1002/jmri.20771. View

15.

Jafari R, Sheth S, Spincemaille P, Nguyen T, Prince M, Wen Y . Rapid automated liver quantitative susceptibility mapping. J Magn Reson Imaging. 2019; 50(3):725-732. PMC: 6929208. DOI: 10.1002/jmri.26632. View

16.

de Rochefort L, Liu T, Kressler B, Liu J, Spincemaille P, Lebon V . Quantitative susceptibility map reconstruction from MR phase data using bayesian regularization: validation and application to brain imaging. Magn Reson Med. 2009; 63(1):194-206. DOI: 10.1002/mrm.22187. View

17.

Gallego-Duran R, Cerro-Salido P, Gomez-Gonzalez E, Pareja M, Ampuero J, Rico M . Imaging biomarkers for steatohepatitis and fibrosis detection in non-alcoholic fatty liver disease. Sci Rep. 2016; 6:31421. PMC: 4981860. DOI: 10.1038/srep31421. View

18.

Dong J, Liu T, Chen F, Zhou D, Dimov A, Raj A . Simultaneous phase unwrapping and removal of chemical shift (SPURS) using graph cuts: application in quantitative susceptibility mapping. IEEE Trans Med Imaging. 2014; 34(2):531-40. DOI: 10.1109/TMI.2014.2361764. View

19.

Kleiner D, Brunt E, Van Natta M, Behling C, Contos M, Cummings O . Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005; 41(6):1313-21. DOI: 10.1002/hep.20701. View

20.

Balassy C, Feier D, Peck-Radosavljevic M, Wrba F, Witoszynskyj S, Kiefer B . Susceptibility-weighted MR imaging in the grading of liver fibrosis: a feasibility study. Radiology. 2013; 270(1):149-58. DOI: 10.1148/radiol.13122440. View